{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T11:18:17Z","timestamp":1774264697857,"version":"3.50.1"},"reference-count":102,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.ncl.2019.01.015","type":"journal-article","created":{"date-parts":[[2019,3,16]],"date-time":"2019-03-16T06:25:44Z","timestamp":1552717544000},"page":"359-381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Autoimmune Encephalitides"],"prefix":"10.1016","volume":"37","author":[{"given":"David S.","family":"Younger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ncl.2019.01.015_bib1","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1212\/WNL.0000000000003414","article-title":"NMDA receptor encephalitis and other antibody-mediated disorders of the synapse: the 2016 Cotzias Lecture","volume":"87","author":"Dalmau","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2019.01.015_bib2","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nrneurol.2012.99","article-title":"Neuronal autoantigens--pathogenesis, associated disorders and antibody testing","volume":"8","author":"Lancaster","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.ncl.2019.01.015_bib3","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A\u00a0clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2019.01.015_bib4","first-page":"448","article-title":"Adult primary central nervous system vasculitis","volume":"19","author":"Salvarani","year":"2017","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.ncl.2019.01.015_bib5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/BOR.0b013e3282f3177a","article-title":"Central nervous system vasculitis in children","volume":"20","author":"Elbers","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ncl.2019.01.015_bib6","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ebcr.2017.07.005","article-title":"New onset refractory status epilepticus due to primary angiitis of the central nervous system","volume":"8","author":"Matar","year":"2017","journal-title":"Epilepsy Behav Case Rep"},{"key":"10.1016\/j.ncl.2019.01.015_bib7","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1161\/STROKEAHA.116.013874","article-title":"Diagnostic yield and safety of brain biopsy for suspected primary central nervous system angiitis","volume":"47","author":"Torres","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.ncl.2019.01.015_bib8","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/brain\/91.3.481","article-title":"\u201cLimbic encephalitis\u201d and its association with carcinoma","volume":"91","author":"Corsellis","year":"1968","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2019.01.015_bib9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00005792-199203000-00001","article-title":"Anti-Hu associated paraneoplastic encephalomyelitis\/sensory neuronopathy: a clinical study of 71 patients","volume":"71","author":"Dalmau","year":"1991","journal-title":"Medicine"},{"key":"10.1016\/j.ncl.2019.01.015_bib10","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/ana.410230518","article-title":"An antineuronal autoantibody in paraneoplastic opsoclonus","volume":"23","author":"Budde-Steffen","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2019.01.015_bib11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/mus.23783","article-title":"Ri\/Nova gene-associated paraneoplastic subacute motor neuronopathy","volume":"47","author":"Younger","year":"2013","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2019.01.015_bib12","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/ana.410140603","article-title":"Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma","volume":"14","author":"Greenlee","year":"1983","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2019.01.015_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/brain\/122.1.27","article-title":"Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders","volume":"122","author":"Dalmau","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2019.01.015_bib14","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1056\/NEJM199906103402303","article-title":"A\u00a0serological marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer","volume":"340","author":"Voltz","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2019.01.015_bib15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00401-001-0498-0","article-title":"Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis","volume":"103","author":"Bernal","year":"2002","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ncl.2019.01.015_bib16","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1212\/WNL.55.12.1823","article-title":"Limbic encephalitis not associated with neoplasm as a cause of temporal lobe epilepsy","volume":"55","author":"Bien","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2019.01.015_bib17","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1056\/NEJM198804213181602","article-title":"Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type 1 diabetes","volume":"318","author":"Solimena","year":"1988","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2019.01.015_bib18","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1212\/01.wnl.0000327342.58936.e0","article-title":"Stiff-person syndrome with amphiphysin antibodies: distinctive features of a rare disease","volume":"71","author":"Murinson","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2019.01.015_bib19","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/brain\/awh077","article-title":"Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis","volume":"127","author":"Vincent","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2019.01.015_bib20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.24200","article-title":"Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms","volume":"76","author":"Irani","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2019.01.015_bib21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.1097","article-title":"Potassium channel antibodies in two patients with reversible limbic encephalitis","volume":"50","author":"Buckley","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2019.01.015_bib22","first-page":"509","article-title":"Antibodies and neuronal autoimmune disorders of the CNS","volume":"257","author":"Graus","year":"2010","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.ncl.2019.01.015_bib23","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/brain\/aws082","article-title":"Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis","volume":"135","author":"Bien","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2019.01.015_bib24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/B978-0-444-63432-0.00007-4","article-title":"Neuropathology of autoimmune encephalitides","volume":"133","author":"Bauer","year":"2016","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.ncl.2019.01.015_bib25","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1055\/s-2004-861540","article-title":"Paraneoplastic disorders of the central nervous system: update on diagnostic criteria and treatment","volume":"24","author":"Bataller","year":"2004","journal-title":"Semin Neurol"},{"key":"10.1016\/j.ncl.2019.01.015_bib26","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2019.01.015_bib27","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1212\/WNL.0b013e318227b176","article-title":"Progressive encephalomyelitis with rigidity and myoclonus: glycine and NMDA receptor antibodies","volume":"77","author":"Turner","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2019.01.015_bib28","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/nyas.12553","article-title":"Autoimmune encephalopathies","volume":"1338","author":"Leypoldt","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ncl.2019.01.015_bib29","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/brain\/awh526","article-title":"Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates","volume":"128","author":"Ances","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2019.01.015_bib30","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1592\/phco.28.6.730","article-title":"The case for autoimmunity in the etiology of schizophrenia","volume":"28","author":"Goldsmith","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ncl.2019.01.015_bib31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12974-018-1067-y","article-title":"A\u00a0clinical approach to new-onset psychosis associated with immune dysregulation: the concept of autoimmune psychosis","volume":"15","author":"Najjar","year":"2018","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.ncl.2019.01.015_bib32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jneuroim.2010.02.015","article-title":"High levels of anti-GAD65 and anti-Ro52 autoantibodies in a patient with major depressive disorder showing psychomotor disturbance","volume":"222","author":"Ching","year":"2010","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.ncl.2019.01.015_bib33","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1176\/jnp.23.1.jnp90","article-title":"The emerging link between autoimmune disorders and neuropsychiatric disease","volume":"23","author":"Kayser","year":"2011","journal-title":"J\u00a0Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.ncl.2019.01.015_bib34","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1139\/jpn.0441","article-title":"The role of the hippocampus in the pathophysiology of major depression","volume":"29","author":"Campbell","year":"2004","journal-title":"J\u00a0Psychiatry Neurosci"},{"key":"10.1016\/j.ncl.2019.01.015_bib35","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1017\/S1461145703003729","article-title":"Desipramine treatment reduces the long-term behavioural and neurochemical sequelae of early-life maternal separation","volume":"6","author":"MacQueen","year":"2003","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.ncl.2019.01.015_bib36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJMra073096","article-title":"Major depressive disorder","volume":"358","author":"Belmaker","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2019.01.015_bib37","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4236\/wjns.2017.73027","article-title":"Autoimmune encephalitides","volume":"7","author":"Younger","year":"2017","journal-title":"World J Neurosci"},{"key":"10.1016\/j.ncl.2019.01.015_bib38","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1038\/nn958","article-title":"Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma","volume":"5","author":"Gilbertson","year":"2002","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.ncl.2019.01.015_bib39","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/mus.25565","article-title":"GAD65 neurological autoimmunity","volume":"56","author":"McKeon","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2019.01.015_bib40","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/mus.20653","article-title":"Rigidity and spasms from autoimmune encephalomyelopathies: stiff person syndrome","volume":"34","author":"Espay","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2019.01.015_bib41","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1468-1331.2011.03609.x","article-title":"Prevalence and immunologic spectrum of temporal lobe epilepsy with glutamic acid decarboxylase antibodies","volume":"19","author":"Falip","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ncl.2019.01.015_bib42","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/ana.21917","article-title":"Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis","volume":"67","author":"Malter","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2019.01.015_bib43","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1017\/cjn.2016.13","article-title":"Limbic encephalitis: associated with GAD65 antibodies: brief review of the relevant literature","volume":"43","author":"Gagnon","year":"2016","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.ncl.2019.01.015_bib44","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0140-6736(05)79192-3","article-title":"Temporal lobe epilepsy associated with glutamic-acid-decarboxylase autoantibodies","volume":"352","author":"Giometto","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ncl.2019.01.015_bib45","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1212\/01.wnl.0000276946.08412.ef","article-title":"Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy","volume":"69","author":"Bien","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2019.01.015_bib46","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/WNN.0b013e31828b6531","article-title":"Neuropsychiatric autoimmune encephalitis without VGKC-complex, NMDAR, and GAD autoantibodies: case report and literature review","volume":"26","author":"Najjar","year":"2013","journal-title":"Cogn Behav Neurol"},{"key":"10.1016\/j.ncl.2019.01.015_bib47","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/WNN.0b013e3182248193","article-title":"Spontaneously resolving seronegative autoimmune limbic encephalitis","volume":"24","author":"Najjar","year":"2011","journal-title":"Cogn Behav Neurol"},{"key":"10.1016\/j.ncl.2019.01.015_bib48","first-page":"526","article-title":"Limbic encephalitis: the new cell membrane antigens and a proposal of clinical-immunological classification with therapeutic implications","volume":"22","author":"Dalmau","year":"2007","journal-title":"Neurologia"},{"key":"10.1016\/j.ncl.2019.01.015_bib49","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1212\/WNL.0b013e3181fc2a06","article-title":"Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin","volume":"75","author":"Pr\u00fcss","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2019.01.015_bib50","first-page":"419","article-title":"Autoimmune N-methyl-D-aspartate glutamate receptor antibodies in patient with an initial diagnosis of schizophrenia: specific relevance of IgG NR 1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis","volume":"68","author":"Thomas","year":"2014","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.ncl.2019.01.015_bib51","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1473-3099(10)70222-X","article-title":"Causes of encephalitis and differences in their clinical presentations in England: a multicenter, population-based prospective study","volume":"10","author":"Granerod","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ncl.2019.01.015_bib52","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1212\/01.wnl.0000278388.90370.c3","article-title":"Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal","volume":"70","author":"Izuka","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2019.01.015_bib53","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2019.01.015_bib54","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/ncpneuro0493","article-title":"A\u00a0patient with encephalitis associated with NMDA receptor antibodies","volume":"3","author":"Sansing","year":"2007","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/j.ncl.2019.01.015_bib55","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/brain\/awq113","article-title":"N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly nonparaneoplastic disorder of both sexes","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2019.01.015_bib56","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factor for long-term outcome in a patient with N-methyl-D-aspartate (NMDA) receptor encephalitis: a cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2019.01.015_bib57","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1212\/WNL.0b013e318228c136","article-title":"Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis","volume":"77","author":"Martinez-Hernandez","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2019.01.015_bib58","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3174\/ajnr.A5086","article-title":"Autoimmune encephalitis: pathophysiology and imaging review of an overlooked diagnosis","volume":"38","author":"Kelley","year":"2017","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.ncl.2019.01.015_bib59","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2019.01.015_bib60","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s00247-005-1402-1","article-title":"Paraneoplastic limbic encephalitis in a teenage girl with an immature ovarian teratoma","volume":"35","author":"Stein-Wexler","year":"2005","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.ncl.2019.01.015_bib61","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00401-009-0582-4","article-title":"Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma","volume":"118","author":"T\u00fcz\u00fcn","year":"2009","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ncl.2019.01.015_bib62","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1468-1331.2010.03180.x","article-title":"Brain immunohistopathological study in a patient with anti-NMDAR encephalitis","volume":"18","author":"Camdessanche","year":"2011","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ncl.2019.01.015_bib63","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1523\/JNEUROSCI.0167-10.2010","article-title":"Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis","volume":"30","author":"Hughes","year":"2010","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.ncl.2019.01.015_bib64","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","article-title":"Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series","volume":"9","author":"Lai","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2019.01.015_bib65","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2019.01.015_bib66","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/ana.410410215","article-title":"Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia","volume":"41","author":"Hart","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2019.01.015_bib67","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1093\/brain\/awl084","article-title":"Neuromyotonia and limbic encephalitis sera target mature Shaker-type K+ channels: subunit specificity correlates with clinical manifestations","volume":"129","author":"Kleopa","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2019.01.015_bib68","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.3201\/eid1909.130064","article-title":"New estimates of incidence of encephalitis in England","volume":"19","author":"Granerod","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ncl.2019.01.015_bib69","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.braindev.2012.09.012","article-title":"VGKG complex antibodies in pediatric severe acute encephalitis: a study and literature review","volume":"35","author":"Lin","year":"2013","journal-title":"Brain Dev"},{"key":"10.1016\/j.ncl.2019.01.015_bib70","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/B978-0-444-63432-0.00011-6","article-title":"Voltage-gated potassium channel-complex autoimmunity and associated clinical syndromes","volume":"133","author":"Irani","year":"2016","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.ncl.2019.01.015_bib71","doi-asserted-by":"crossref","first-page":"881","DOI":"10.4065\/mcp.2010.0326","article-title":"Autoimmune dementia: clinical course and predictors of immunotherapy response","volume":"85","author":"Flanagan","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ncl.2019.01.015_bib72","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1192\/bjp.bp.105.012864","article-title":"Psychiatric presentation of voltage-gated potassium channel antibody-associated encephalopathy. Case report","volume":"189","author":"Parthasarathi","year":"2006","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.ncl.2019.01.015_bib73","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/ene.12482","article-title":"More than memory impairment in voltage-gated potassium channel complex encephalopathy","volume":"21","author":"Bettcher","year":"2014","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ncl.2019.01.015_bib74","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/ng832","article-title":"Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features","volume":"30","author":"Kalachikov","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.ncl.2019.01.015_bib75","doi-asserted-by":"crossref","first-page":"18161","DOI":"10.1523\/JNEUROSCI.3506-13.2013","article-title":"Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptor","volume":"33","author":"Ohkawa","year":"2013","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.ncl.2019.01.015_bib76","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1073\/pnas.0914537107","article-title":"Disruption of LGI1-linked synaptic complex causes synaptic transmission and epilepsy","volume":"107","author":"Fukata","year":"2010","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.ncl.2019.01.015_bib77","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4236\/wjns.2017.71002","article-title":"Limbic encephalitis associated with voltage-gated potassium channel-complex antibodies: patient report and literature review","volume":"7","author":"Younger","year":"2017","journal-title":"World J Neurosci"},{"key":"10.1016\/j.ncl.2019.01.015_bib78","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1212\/WNL.0b013e3182698cab","article-title":"Chronic pain as a manifestation of potassium channel-complex autoimmunity","volume":"79","author":"Klein","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2019.01.015_bib79","article-title":"Clinical-pathologic correlations in VGKC-subtyped autoimmune painful polyneuropathy","author":"Lahoria","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2019.01.015_bib80","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cell.2011.08.040","article-title":"CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits","volume":"147","author":"Pe\u00f1agarikano","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ncl.2019.01.015_bib81","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/ajmg.b.31241","article-title":"Genetic variation in CNTNAP2 alters brain function during linguistic processing in healthy individuals","volume":"156B","author":"Whalley","year":"2011","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.ncl.2019.01.015_bib82","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/jnnp-2013-305218","article-title":"Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre","volume":"85","author":"Paterson","year":"2014","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ncl.2019.01.015_bib83","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.yebeh.2010.01.017","article-title":"Improvement of non-paraneoplastic voltage-gated potassium channel antibody-associated limbic encephalitis without immunosuppressive therapy","volume":"17","author":"Gast","year":"2010","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.ncl.2019.01.015_bib84","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ebcr.2015.02.002","article-title":"A\u00a0case study of voltage-gated potassium channel antibody-related limbic encephalitis with PET\/MRI findings","volume":"4","author":"Day","year":"2015","journal-title":"Epilepsy Behav Case Rep"},{"key":"10.1016\/j.ncl.2019.01.015_bib85","first-page":"2744","article-title":"Cerebral FDG-PET and MRI findings in autoimmune limbic encephalitis: correlation with autoantibody types","volume":"260","author":"Baumgartner","year":"2013","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.ncl.2019.01.015_bib86","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jns.2007.11.004","article-title":"CSF findings in patients with voltage gated potassium channel antibody associated limbic encephalitis","volume":"268","author":"Jarius","year":"2008","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.ncl.2019.01.015_bib87","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/ageing\/afl045","article-title":"Autoimmune limbic encephalitis causing fits, rapidly progressive confusion and hyponatremia","volume":"35","author":"Dunstan","year":"2006","journal-title":"Age Ageing"},{"key":"10.1016\/j.ncl.2019.01.015_bib88","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1111\/j.1468-1331.2007.01924.x","article-title":"An autopsy case of limbic encephalitis with voltage-gated potassium channel antibodies","volume":"14","author":"Park","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ncl.2019.01.015_bib89","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1212\/WNL.0b013e3181a55eb3","article-title":"Histopathology of VGKC antibody-associated limbic encephalitis","volume":"72","author":"Khan","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2019.01.015_bib90","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/jnnp.2006.100644","article-title":"Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes","volume":"78","author":"Bataller","year":"2007","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ncl.2019.01.015_bib91","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/hmg\/11.9.1119","article-title":"Mutations in the LGI1\/Epitemprin gene on 10q24 cause autosomal dominant lateral temporal epilepsy","volume":"11","author":"Morante-Redolat","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ncl.2019.01.015_bib92","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0140-6736(66)92876-5","article-title":"Hashimoto\u2019s disease and encephalopathy","volume":"2","author":"Brain","year":"1966","journal-title":"Lancet"},{"key":"10.1016\/j.ncl.2019.01.015_bib93","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S0140-6736(76)92207-8","article-title":"Hashimoto\u2019s disease, encephalopathy, and splenic atrophy","volume":"1","author":"Jellinek","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.ncl.2019.01.015_bib94","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1001\/archneur.60.2.164","article-title":"Hashimoto encephalopathy. Syndrome or myth?","volume":"60","author":"Chong","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ncl.2019.01.015_bib95","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-5793(02)03307-0","article-title":"Proteomic analysis of human brain identifies \u03b1-enolase as a novel autoantigen in Hashimoto\u2019s encephalopathy","volume":"528","author":"Ochi","year":"2002","journal-title":"FEBS Lett"},{"issue":"10","key":"10.1016\/j.ncl.2019.01.015_bib96","doi-asserted-by":"crossref","first-page":"e6181","DOI":"10.1097\/MD.0000000000006181","article-title":"Limbic encephalitis associated with anti-NH2-terminal of a-enolase antibodies. A clinical subtype of Hashimoto encephalopathy","volume":"96","author":"Kishitani","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.ncl.2019.01.015_bib97","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s10072-011-0750-x","article-title":"Hashimoto\u2019s encephalopathy presenting with micrographia as a typical feature of parkinsonism","volume":"33","author":"Inoue","year":"2012","journal-title":"Neurol Sci"},{"key":"10.1016\/j.ncl.2019.01.015_bib98","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4236\/wjns.2017.73026","article-title":"Hashimoto\u2019s thyroiditis and encephalopathy","volume":"7","author":"Younger","year":"2017","journal-title":"World J Neurosci"},{"key":"10.1016\/j.ncl.2019.01.015_bib99","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1212\/WNL.54.3.769","article-title":"Hashimoto encephalopathy: a brainstem encephalitis?","volume":"54","author":"Nolte","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2019.01.015_bib100","first-page":"191","article-title":"Isolated angiitis of the CNS associated with Hashimoto's disease","volume":"32","author":"Shibata","year":"1992","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.ncl.2019.01.015_bib101","doi-asserted-by":"crossref","DOI":"10.1177\/0961203317721752","article-title":"Serum levels of anti-a-enolase activity in untreated systemic lupus erythematosus patients correlates with 24-hour protein and D-dimer","author":"Li","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.ncl.2019.01.015_bib102","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1007\/PL00000910","article-title":"Multifunctional alpha-enolase: its role in diseases","volume":"58","author":"Pancholi","year":"2001","journal-title":"Cell Mol Life Sci"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861919300155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861919300155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:16:27Z","timestamp":1760004987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861919300155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":102,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0733861919300155"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2019.01.015","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune Encephalitides","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2019.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}